Effect of Continuous Glucose Monitoring System on Glycemic Control in Non-insulin-Treated Elderly People With Type 2 Diabetes

NCT07007676 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2026-04-13

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if continuous glucose monitoring system works to improve glucose control in non-insulin-treated older adults with type 2 diabetes. The main questions it aims to answer are:

* Dose the use of continuous glucose monitoring system improve glucose control in older adults with type 2 diabetes treated with oral antidiabetic drugs only?
* Dose the use of continuous glucose monitoring system affect psychological outcomes in older adults with type 2 diabetes treated with oral antidiabetic drugs only? Researchers will compare continuous glucose monitoring to standard blood glucose monitoring to see if continuous glucose monitoring works better in glucose management.

Participants will:

* Wear continuous glucose monitoring every 2 months or standard blood glucose monitoring for 6 months
* Visit the clinic once every 2 months for follow-up
* Keep a diary of their blood glucose when continuous glucose monitoring was not used

Conditions

  • Diabetes Mellitus Type 2

Interventions

DEVICE

real-time CGM

real-time CGM can provide real-time tracking of glucose levels, and offer glucose trend graphs and user-configurable low and high glucose alerts.

Sponsors & Collaborators

  • Shenzhen Center for Chronic Disease Control

    collaborator OTHER
  • Shenzhen Baoan District People 's Hospital

    collaborator UNKNOWN
  • Shenzhen Haile Community Health Service Station

    collaborator UNKNOWN
  • Shenzhen Buxin Community Health Service Center

    collaborator UNKNOWN
  • Shenzhen Dalang Community Health Service Center

    collaborator UNKNOWN
  • Shenzhen Haihua Community Health Service Center

    collaborator UNKNOWN
  • Shenzhen Pingzhou Community Health Service Center

    collaborator UNKNOWN
  • Shenzhen Fifth Avenue Health Service Station

    collaborator UNKNOWN
  • Shenzhen Haifu Health Service Station

    collaborator UNKNOWN
  • Shenzhen Haile Huafu Health Service Station

    collaborator UNKNOWN
  • Shenzhen Haiyu Health Service Station

    collaborator UNKNOWN
  • Shenzhen Jiaan Health Service Station

    collaborator UNKNOWN
  • Shenzhen Jiari Mingju Health Service Station

    collaborator UNKNOWN
  • Shenzhen Jiangangshan Health Service Center

    collaborator UNKNOWN
  • Shenzhen Xinan Lake Health Service Station

    collaborator UNKNOWN
  • Shenzhen Xingdong Health Service Station

    collaborator UNKNOWN
  • Shenzhen Zhongliang Chuangxin Health Service Station

    collaborator UNKNOWN
  • Shanghai 6th People's Hospital

    lead OTHER

Principal Investigators

  • Jian Zhou, Prof., Dr., Ph.D · Shanghai 6th People's Hospital

  • Xiaobing Wu, Ph.D · Shenzhen Center for Chronic Disease Control

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-14
Primary Completion
2027-02-28
Completion
2027-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07007676 on ClinicalTrials.gov